STOCK TITAN

Millennium entities (IMUX) disclose 7.0% beneficial ownership in Immunic common stock

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Immunic, Inc. is the subject of an amended Schedule 13G filing reporting significant beneficial ownership of its common stock. Integrated Core Strategies (US) LLC reports shared voting and dispositive power over 960,816 shares, representing 6.9% of the class. Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report shared voting and dispositive power over 969,547 shares, representing 7.0% of the class. These ownership percentages give effect to warrants deemed exercisable within sixty days under Rule 13d-3(d)(1)(i).

Positive

  • None.

Negative

  • None.
Shares beneficially owned (Integrated Core Strategies) 960,816 shares Beneficial ownership of Immunic common stock; Schedule 13G/A cover page Item 9
Percent of class (Integrated Core Strategies) 6.9% Percentage of Immunic common stock class; Schedule 13G/A cover page Item 11
Shares beneficially owned (Millennium entities & Englander) 969,547 shares Beneficial ownership of Immunic common stock for Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander
Percent of class (Millennium entities & Englander) 7.0% Percentage of Immunic common stock class reported by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander
Rule reference for warrant treatment Rule 13d-3(d)(1)(i) Ownership includes shares issuable upon exercise of warrants deemed exercisable within sixty days
beneficially owned financial
"Amount beneficially owned: See response to Item 9 on each cover page."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared Voting Power 969,547.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 969,547.00"
Rule 13d-3(d)(1)(i) regulatory
"gives effect to shares deemed to be outstanding as provided in Rule 13d-3(d)(1)(i)"
Schedule 13G regulatory
"For each reporting person, the percent of the class reported herein as beneficially owned"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake in Immunic, Inc. (IMUX) does Integrated Core Strategies (US) LLC report?

Integrated Core Strategies (US) LLC reports beneficial ownership of 960,816 shares of Immunic common stock, representing 6.9% of the class, with shared voting and shared dispositive power over all of those shares.

What percentage of Immunic, Inc. (IMUX) does Millennium Management LLC report owning?

Millennium Management LLC reports beneficial ownership of 969,547 shares of Immunic common stock, representing 7.0% of the class, with shared voting and shared dispositive power over all reported shares.

How many Immunic, Inc. (IMUX) shares does Israel A. Englander report beneficially owning?

Israel A. Englander reports beneficial ownership of 969,547 shares of Immunic common stock, or 7.0% of the class, with shared voting and shared dispositive power through entities he controls.

How is beneficial ownership in Immunic, Inc. (IMUX) determined in this Schedule 13G/A?

Beneficial ownership percentages are calculated under Rule 13d-3(d)(1)(i), which includes shares issuable upon exercise of warrants deemed exercisable within sixty days when computing each reporting person’s stake.

Do the reporting persons claim sole voting power over Immunic, Inc. (IMUX) shares?

No. Each reporting person reports 0 shares with sole voting or dispositive power and instead reports only shared voting and shared dispositive power over their respective Immunic share positions.





4525EP200

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:08/05/2026
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:08/05/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:08/05/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:08/05/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of August 5, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.